Abstract

Background - Pathogen Reduction Technologies (PRTs) are broad spectrum nucleic acid replication-blocking antimicrobial treatments designed to mitigate risk of infection from blood product transfusions. Thiazole Orange (TO), a photosensitizing nucleic acid dye, was previously shown to photoinactivate several types of bacterial and viral pathogens in RBC suspensions without adverse effects on function. In this report we extended TO treatment to platelet concentrates (PCs) to see whether it is compatible with in vitro platelet functions also, and thus, could serve as a candidate technology for further evaluation.
Material and methods - PCs were treated with TO, and an effective treatment dose for inactivation of Staphylococci was identified. Platelet function and physiology were then evaluated by various assays in vitro.
Results - Phototreatment of PCs yielded significant reduction (≥4-log) in Staphylococci at TO concentrations ≥20 µM. However, treatment with TO reduced aggregation response to collagen over time, and platelets became unresponsive by 24 hours post-treatment (from >80% at 1 h to 0% at 24 h). TO treatment also significantly increased CD62P expression (<1% CD62P+ for untreated and >50% for TO treated at 1 h) and induced apoptosis in platelets (<1% Annexin V+ for untreated and >50% for TO treated at 1 h) and damaged mitochondrial DNA. A mitochondria-targeted antioxidant and ROS scavenger Mito-Tempo mitigated these adverse effects.
Discussion - The results demonstrate that TO compromises mitochondria and perturbs internal signaling that activates platelets and triggers apoptosis. This study illustrates that protecting platelet mitochondria and its functions should be a fundamental consideration in selecting a PRT for transfusion units containing platelets, such as PCs.

Downloads

Authors

Portia Gough - OBRR/LCH in the Center for Biologics Evaluation and Research (CBER), US Food and Drug Administration Silver Spring, MD

Todd Getz - American Red Cross Holland Laboratory, Rockville, MD, United States of America

Silvia De Paoli - OBRR/LCH in the Center for Biologics Evaluation and Research (CBER), US Food and Drug Administration Silver Spring, MD

Stephen Wagner - American Red Cross Holland Laboratory, Rockville, MD, United States of America

Chintamani Atreya - OBRR/LCH in the Center for Biologics Evaluation and Research (CBER), US Food and Drug Administration Silver Spring, MD

  • Abstract viewed - 144 times
  • PDF downloaded - 80 times